| 期 |
标题 |
文件 |
| 卷 28, 编号 2 (2023) |
Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors |
(Rus)
|
|
Lazarev A., Petrova V., Lazarev S., Repkina T., Terekhova S., Obеremok P., Osipov I., Nikolaeva M., Ganov D.
|
| 卷 28, 编号 2 (2023) |
Optimization of algorithms for in vivo preclinical screening of compounds with an alleged antitumor effect |
(Rus)
|
|
Dodokhova M., Voronova O., Alkhusein-Kulyaginova M., Gulyan M., Kotieva E., Korobka S., Kotieva V., Karapetyan K., Vlasova N., Shpakovsky D., Milaeva E., Kotieva I.
|
| 卷 28, 编号 2 (2023) |
Comparative evaluation of the perioperative anesthesia methods for cancer patients undergoing pancreaticoduodenectomy |
(Rus)
|
|
Zakharenkova I., Khoronenko V., Trifanov V.
|
| 卷 28, 编号 2 (2023) |
Immunophenotype of dendritic cell differentiation markers in breast cancer in in-vitro conditions |
(Rus)
|
|
Golderova A., Nikolaeva I., Troev I., Zharnikova T., Nikiforov P.
|
| 卷 28, 编号 2 (2023) |
Matrix metalloproteinase MMP-7 as a new prognostic biomarker for gastric cancer |
(Rus)
|
|
Kiseleva A., Antsupova M., Semenkov A., Bykov I.
|
| 卷 28, 编号 1 (2023) |
Cytotoxic and Anticancer Activity of Pharmacological Pairs of C115H Methionine–Gamma-lyase and S-Propyl-L-Cysteine Sulfoxide |
(Rus)
|
|
Abo Qoura L., Karshieva S., Borisova J., Pokrovsky V.
|
| 卷 28, 编号 1 (2023) |
Preclinical positron emission computed tomography of prolonged tumor growth after lutetium-177 prostate-specific membrane antigen treatment in xenograft model of human prostate cancer |
(Rus)
|
|
Klementyeva O., Lipengolts A., Grigorieva E., Smirnova A., Finogenova Y., Shpakova K., Skribitsky V., Lagodzinskaya Y.
|
| 卷 28, 编号 1 (2023) |
The effect of NBS1 heterozygous inactivating mutation in a model of 7,12-dimethylbenz[a]anthracene-induced carcinogenesis in mice |
(Rus)
|
|
Yurova M., Golubev A., Fedoros E., Tumanyan I., Von Y., Semenov A., Otradnova E., Imyanitov E.
|
| 卷 28, 编号 1 (2023) |
PC Kz is the novel human prostate cancer model in vitro and in vivo |
(Rus)
|
|
Sokolova D., Khan I., Zhdanov D., Demidova E., Krivchenko V., Aidossov C., Pokrovsky V.
|
| 卷 28, 编号 1 (2023) |
Antiproliferative activity of the novel CYP17A1 inhibitor alsevirone |
(Rus)
|
|
Khan I., Latysheva A., Zolottsev V., Demidova E., Spirina T., Karshieva S., Sokolova D., Yakunina M., Komarova M., Misharin A., Pokrovsky V.
|
| 卷 27, 编号 6 (2022) |
Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors |
(Rus)
|
|
Lazarev A., Petrova V., Lazarev S., Vakhlova Z., Nikolaeva M., Repkina T., Terekhova S., Osipov I., Shlyaptseva E., Komarova A., Ganov D.
|
| 卷 27, 编号 6 (2022) |
Analysis of surgical treatment of patients with pancreatic cancer at the Samara Regional Clinical Oncological Dispensary |
(Rus)
|
|
Kaganov O., Orlov A., Kozlov A., Shvets D., Mikolenko N.
|
| 卷 27, 编号 1 (2022) |
MiR-155-5p-mediated increase in p53 content induced by dacarbazine in melanoma cells |
(Rus)
|
|
Dashkova D., Esimbekova A., Kotova K., Ruksha T.
|
| 卷 27, 编号 5 (2022) |
Lung cancer and HIV |
(Rus)
|
|
Manikhas G., Zakharenko A., Polezhaev D., Panteleev A., Gusev D., Panteleeva O., Zakirov A., Gavrilov P.
|
| 卷 27, 编号 5 (2022) |
Analysis of surgical treatment complications in patients diagnosed with pancreatic cancer |
(Rus)
|
|
Kaganov O., Orlov A., Kozlov A., Shvets D., Mikolenko N.
|
| 卷 27, 编号 5 (2022) |
Clinical results of cervix cancer treatment using various technologies in radiation therapy |
(Rus)
|
|
Kravets O., Kurmanova A., Bogatyrev V.
|
| 卷 27, 编号 4 (2022) |
Cytodiagnosis of pleural effusions according to the International System for Reporting Serous Fluid Cytopathology: retrospective analysis of oncological dispensary experience |
(Rus)
|
|
Grigoruk O., Vikhlyanov I., Bazulina L., Elchaninova S., Lazarev A.
|
| 卷 27, 编号 4 (2022) |
Evaluation of the effectiveness of multicomponent treatment in the progression of primary low-grade brain gliomas. Own experience |
(Rus)
|
|
Sarycheva M., Vazhenin A., Mozerova E.
|
| 卷 27, 编号 4 (2022) |
Malignant neoplasms of the respiratory tract and thoracic organs in the remote period in males of Altai krai affected by first nuclear test at Semipalatinsk test site |
(Rus)
|
|
Kovrigin A., Kolyado I., Lubennikov V., Vikhlyanov I., Lazarev A., Shoikhet Y.
|
| 卷 27, 编号 4 (2022) |
Analysis of the incidence of lung cancer in the Krasnoyarsk Territory. Justification of the Introduction of innovative methods of early diagnosis |
(Rus)
|
|
Zukov R., Safontsev I., Klimenok M., Zabrodskaya T., Krat A., Kichkailo A., Zamay T.
|
| 卷 27, 编号 4 (2022) |
Pancreatic cancer surgery — experience of one medical center |
(Rus)
|
|
Kaganov O., Kozlov A., Shvets D., Mikolenko N.
|
| 卷 26, 编号 5 (2021) |
The comparative analysis of transradial and transfemoral vascular approaches for chemoembolization of pancreatic cancer |
(Rus)
|
|
Khayrutdinov E., Gromov D., Arablinskiy A.
|
| 卷 26, 编号 5 (2021) |
Epidemiology of breast cancer in the Krasnoyarsk region |
(Rus)
|
|
Zyuzyukina A., Komissarovа V., Gasimli D., Safontsev I., Zukov R.
|
| 卷 26, 编号 3 (2021) |
Anthropometric and topometric characterization of patients with breast cancer |
(Rus)
|
|
Zyuzyukina A., Gasymly D., Komissarova V., Chuyashenko A., Zukov R.
|
| 卷 26, 编号 3 (2021) |
Traditional and liquid-based cytology in the diagnosis of non-tumor lesions and endometrial tumors |
(Rus)
|
|
Karpova A., Shabalova I., Sozaeva L.
|
| 卷 26, 编号 2 (2021) |
Phagocytic and chemiluminescent activity of blood neutrophils in patients with bladder cancer |
(Rus)
|
|
Savchenko A., Zukov R., Firsov M., Slepov E., Belenyuk V., Gvozdev I., Borisov A.
|
| 卷 26, 编号 2 (2021) |
Prognostic value of quantitative assessment of macrophage content (CD68+) in the peritumoral zone of clear cell renal cell carcinoma |
(Rus)
|
|
Bobrov I., Lazarev A., Cherdantseva T., Klimachev I., Klimachev V., Myadelets M., Lepilov A., Dolgatov A., Korsikov N., Dolgatova E., Lushnikova E., Bakarev M.
|
| 卷 26, 编号 1 (2021) |
Molecular biological characteristics of tumors and results of breast cancer treatment in males |
(Rus)
|
|
Zyuzyukina A., Slepov E., Vinnik Y., Zukov R.
|
| 卷 26, 编号 1 (2021) |
Clinical prognostic factors for fibrolamellar liver carcinoma |
(Rus)
|
|
Antonova E., Moroz E., Podlyzny D., Kudashkin N., Volkov A., Dzhanyan I., Laktionov K., Breder V.
|
| 卷 25, 编号 3 (2020) |
Cytological method of diagnostics of pleural effusion using immunocytochemical and molecular genetic techniques |
(Rus)
|
|
Grigoruk O., Pupkova Е., Bazulina L.
|
| 卷 25, 编号 2 (2020) |
Association of gene expression with lymph node breast cancer metastasis |
(Rus)
|
|
Grishina K., Kipkeeva F., Pospekhova N., Khaylenko V., Karpukhin A.
|
| 卷 25, 编号 2 (2020) |
Invasive potential of retroperitoneal well-differentiated liposarcomas depending on the extent of sclerosing component in the tumor |
(Rus)
|
|
Volkov A., Kozlov N., Nered S., Stilidi I., Stroganova A., Archery P., Antonov E., Privezentsev S.
|
| 卷 25, 编号 1 (2020) |
Ripretinib (DCC-2618): a new tyrosine kinase inhibitor for the treatment of metastatic gastrointestinal stromal tumors |
(Rus)
|
|
Filonenko D., Tikhomirova T., Meshcheryakov A.
|
| 1 - 33 的 33 信息 |
|
